KINETIC PARAMETER ANALYSIS OF MYELOPEROXIDASE IN THE PRESENCE OF SOME COSUSBTRATES IN SALIVA OF NEWBORN AT RISK OF SEPSIS

  • ARI YUNANTO Department of Child Health, Faculty of Medicine, Lambung Mangkurat University, Banjarmasin, Indonesia
  • EDI HARTOYO Department of Child Health, Faculty of Medicine, Lambung Mangkurat University, Banjarmasin, Indonesia.
  • ISKANDAR THALIB Department of Child Health, Faculty of Medicine, Lambung Mangkurat University, Banjarmasin, Indonesia
  • NIARSARI ANUGRAHING PUTRI Department of Child Health, Faculty of Medicine, Lambung Mangkurat University, Banjarmasin, Indonesia
  • EKO SUHARTONO Department of Medical Chemistry/Biochemistry, Faculty of Medicine, Lambung Mangkurat University, Banjarbaru, Indonesia

Abstract

Objective: During infection like sepsis, myeloperoxidase (MPO) enzyme will be generated from the neutrophil. This enzyme will catalyze the
oxidation of halide or pseudohalide (Cl, I-, SCN, and Br-) using hydrogen peroxide (H2O2). However, the mechanism by which oxidation of these several
cosubstrates in neonatal sepsis is unknown. Here, we have compared the kinetic parameter of MPO in saliva of newborn at risk of sepsis with or
without the presence of these several cosubstrates.
Methods: In this experiment, saliva samples were taken from newborn in health (n = 20) and risk of sepsis (n = 20). Saliva samples from each group
then homogenized and divided into four groups. Group 1 served as control which contains saliva+H2O2; Group 2 contains saliva+H2O2+Cl−; Group 3
contains saliva+H2O2+I−; and Group 4 contains saliva+H2O2+SCN−. After 1 h incubation, the kinetic parameters (Km and Vmax) were analyzed.
Results: The result shows that in sepsis condition, compared without the presence of some cosubstrates, it seems the addition of some cosubstrate
will increase the affinity between MPO, H2O2, and the cosubstrate. Between these three cosubstrates, it seems in sepsis condition MPO will oxidize Cl−.
Conclusion: In sepsis condition, MPO works by a common mechanism, that is, oxidizing Cl− to hypochlorous acid than another cosubstrate.

Keywords: Myeloperoxidase, Neonatal Sepsis, Saliva

References

1. El-Din EM, El-Sokkary MM, Bassiouny MR, Hassan R. Epidemiology
of neonatal sepsis and implicated pathogens: A study from Egypt.
Biomed Res Int 2015;2015:1-11.
2. Verma P, Berwal PK, Nagaraj N, Swami S, Jivaji P, Narayan S.
Neonatal sepsis: Epidemiology, clinical spectrum, recent antimicrobial
agents and their antibiotic susceptibility pattern. Int J Contemp Pediatr
2015;2:176-80.
3. Dessi A, Pravettoni C, Ottonello G, Birocchi F, Cioglia F, Fanos V.
Neonatal sepsis. J Pediatr Neonatal Individ Med 2014;3:e030273.
4. Joshi G, Kumar A. A review on early and late neonatal sepsis: An
update. J Pharm Res 2017;11:609-16.
5. Yunanto A, Thalib I, Suhartono E. In-vitro effects of some antibiotic
drugs on saliva thiocyanate and oxidation protein products levels on
newborn at risk of sepsis. Int J Pharm Clin Res 2016;8:86-9.
6. Yunanto A, Andayani P, Triyawanti, Suhartono E, Widodo A. Neutrophil
phagocytosis activity compared to myeloperoxidase, hydrogen
peroxidase and lactoferrin levels in saliva of newborn baby with sepsis
risk factors to detect early-onset neonatal sepsis. Int J Pharm Sci Invent
2013;2:18-22.
7. Teng N, Maghzal GJ, Talib J, Rashid I, Lau AK, Stocker R. The roles of
myeloperoxidase in coronary artery disease and its potential implication
in plaque rupture. Redox Rep 2017;22:51-73.
8. Tahboub YR, Abu-Soud HM. Steady-state study of inhibitory effect
of nitrite on myeloperoxidase catalytic activity by hydrogen peroxide
biosensor. Port Electrochim Acta 2010;28:27-38.
9. Davies MJ. Myeloperoxidase-derived oxidation: Mechanisms of
biological damage and its prevention. J Clin Biochem Nutr 2011;48:8-19.
10. Klebanoff SJ. Myeloperoxidase: Friend or foe. J Leukoc Biol
2005;77:598-625.
11. Kania N, Thalib I, Suhartono E. Chlorinative index in liver toxicity
induced by iron. Int J Pharm Clin Res 2016;8:1300-4.
12. Yunanto A, Gunawan P, Iskandar, Suhartono E. Effect of antibiotic
applications on salivary amylase and catalase kinetic parameters
on neonatal at risk of sepsis in vitro. Int J Toxicol Pharm Res
2015;7:269-73.
13. Marisa D, Rudito M, Zagita MG, Biworo A, Suhartono E. Hepatotoxicity
effect of rifampicin and isoniazid via chlorinative stress pathway
mechanism in-vitro. Int J Toxicol Pharm Res 2016;8:18-22.
14. El-Gammasy TM, Abushady NM, Hamza MT, Shaker R. Increase
myeloperoxidase activity as an indicator of neutrophil-induced
inflammation and sepsis in neonates. Egypt Pediatr Allergy Immunol
2015;13:15-20.
15. Nichols SJ, Hazen SL. Myeloperoxidase and cardiovascular disease.
Arterioscler Thromb Vasc Biol 2005;25:1102-11.
16. Lau D, Mollnau H, Eiserich JP, Freeman BA, Daiber A, Gehling UM,
et al. Myeloperoxidase mediates neutrophil activation by association
with CD11b/CD18 integrins. Proc Natl Acad Sci U S A 2005;102:431-6.
17. Stark J, Varga Z, Ghidan A, Vajdovich P, Szombath D, Marczell I,
et al. The effect of indomethacin, myeloperoxidase, and certain steroid
hormones on bactericidal activity: An ex vivo and in vivo experimental
study. Ann Clin Microbiol Antimicrob 2014;13:27.
Statistics
40 Views | 71 Downloads
Citations
How to Cite
YUNANTO, A., HARTOYO, E., THALIB, I., PUTRI, N. A., & SUHARTONO, E. (2021). KINETIC PARAMETER ANALYSIS OF MYELOPEROXIDASE IN THE PRESENCE OF SOME COSUSBTRATES IN SALIVA OF NEWBORN AT RISK OF SEPSIS. International Journal of Applied Pharmaceutics, 13(1), 24-26. https://doi.org/10.22159/ijap.2021.v13s1.Y0072
Section
Full Proceeding Paper